Financials
- Market Capitalization 578.1 M
- Employee 1 315
- Founded 2011
- CEO Ming Hsieh
- Website www.fulgentgenetics.com
- Headquarter Delaware, United States
- FIGI BBG00DR7LTG2
- Industry Diagnostic et Recherche
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-13.36
ratio cours/chiffre d'affaires
2.51
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2362 | OPK Opko Health, Inc. - Common Stock | 1.37 USD | +3.79% | 0.00% | -13.84% | -10.46% | 1.02 B USD | ||
| 2370 | CSTL Castle Biosciences, Inc. - Common stock | 33.11 USD | +0.70% | +1.75% | -6.73% | +34.51% | 1.01 B USD | ||
| 2830 | ACRS Aclaris Therapeutics, Inc. - Common Stock | 3.38 USD | -2.59% | +0.30% | -38.99% | +76.04% | 497.53 M USD | ||
| 2992 | MYGN Myriad Genetics, Inc. - Common Stock | 4.15 USD | +1.72% | -2.12% | +10.67% | -49.82% | 396.95 M USD |